糖尿病患者抗高血压治疗的代谢方法。 - Suppr

Metabolic approaches to antihypertensive treatment in diabetic patients.

作者信息

Cicero Arrigo F, Tocci Giuliano

机构信息

Department of Medical and Surgical Sciences, Sant'Orsola Malpighi, University of Bologna, Bologna, Italy.

Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome 'Sapienza', Sant'Andrea Hospital, Rome and IRCCS Neuromed, Pozzilli (IS), Italy.

出版信息

Hypertens Res. 2015 Dec;38(12):802-3. doi: 10.1038/hr.2015.105. Epub 2015 Oct 1.

DOI:10.1038/hr.2015.105

PMID:26423788

Abstract

摘要

相似文献

Metabolic approaches to antihypertensive treatment in diabetic patients.糖尿病患者抗高血压治疗的代谢方法。

Hypertens Res. 2015 Dec;38(12):802-3. doi: 10.1038/hr.2015.105. Epub 2015 Oct 1.

Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.巴尼地平+氯沙坦与替米沙坦+氢氯噻嗪对高血压合并2型糖尿病患者胰岛素敏感性若干参数影响的比较

Hypertens Res. 2015 Oct;38(10):690-4. doi: 10.1038/hr.2015.57. Epub 2015 May 21.

[Observational study of an AT1-antagonist].[一种血管紧张素Ⅱ1型受体拮抗剂的观察性研究]

MMW Fortschr Med. 2007 Aug 16;149(33-34):37. doi: 10.1007/BF03365120.

Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.替米沙坦/氢氯噻嗪40/12.5毫克和80/12.5毫克固定剂量组合与氯沙坦/氢氯噻嗪50/12.5毫克固定剂量组合治疗轻度至中度原发性高血压的比较：两项多中心、前瞻性、随机、开放标签、盲终点（PROBE）试验的汇总分析

Clin Ther. 2005 Nov;27(11):1795-805. doi: 10.1016/j.clinthera.2005.11.014.

Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.从氨氯地平转换为替米沙坦与小剂量氢氯噻嗪联合治疗的效果。

Hypertens Res. 2009 Sep;32(9):748-52. doi: 10.1038/hr.2009.101. Epub 2009 Jul 10.

Improving hypertension control in patients at cardiovascular risk: the case for telmisartan-based therapy.改善心血管风险患者的高血压控制：基于替米沙坦治疗的情况

Cardiovasc J Afr. 2011 Jan-Feb;22(1):45-6.

A third amlodipine/ARB combination (Twynsta) for hypertension.第三种用于治疗高血压的氨氯地平/ARB复方制剂（Twynsta）。

Med Lett Drugs Ther. 2010 Jan 11;52(1329):2-3.

Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence.高剂量血管紧张素受体阻滞剂与低剂量噻嗪类利尿剂单一固定剂量联合用药在高血压治疗中的作用：有待进一步积累临床证据。

Hypertens Res. 2014 Dec;37(12):1032-4. doi: 10.1038/hr.2014.130. Epub 2014 Sep 4.

[AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].[血管紧张素Ⅱ1型受体阻滞剂的作用各不相同。健忘的患者尤其开始注意到这一点]

MMW Fortschr Med. 2003 Apr 10;145(15):62.

Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.小剂量降压利尿剂联合氯沙坦、替米沙坦或坎地沙坦对高血压患者血清尿酸水平的影响。

Arzneimittelforschung. 2010;60(2):71-5. doi: 10.1055/s-0031-1296251.

本文引用的文献

Hypertens Res. 2015 Oct;38(10):690-4. doi: 10.1038/hr.2015.57. Epub 2015 May 21.

Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey.意大利高血压与心脏调查结果：全科医疗中高血压及高血压相关心脏疾病临床管理的态度与偏好

J Hum Hypertens. 2015 Jul;29(7):409-16. doi: 10.1038/jhh.2014.115. Epub 2014 Dec 18.

From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.从瘦素到其他脂肪因子在健康和疾病中的作用：21 世纪初的事实和展望。

Metabolism. 2015 Jan;64(1):131-45. doi: 10.1016/j.metabol.2014.10.016. Epub 2014 Oct 23.

Challenge for hypertension prevention and control worldwide: the time for action.全球高血压预防与控制面临的挑战：行动时刻已至。

J Clin Hypertens (Greenwich). 2014 Aug;16(8):554-6. doi: 10.1111/jch.12373. Epub 2014 Jul 24.

Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.替米沙坦激活内源性过氧化物酶体增殖物激活受体-δ，可能对人肾小球系膜细胞具有抗纤维化作用。

Hypertens Res. 2014 May;37(5):422-31. doi: 10.1038/hr.2013.157. Epub 2013 Dec 19.

2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理实践指南：ESH/ESC动脉高血压管理特别工作组

J Hypertens. 2013 Oct;31(10):1925-38. doi: 10.1097/HJH.0b013e328364ca4c.

How to avoid the depression of the adherence to antihypertensive treatment?如何避免抗高血压治疗依从性下降？

J Hypertens. 2013 Jul;31(7):1362-3. doi: 10.1097/HJH.0b013e328362a34a.

The metabolic cost of lowering blood pressure with hydrochlorothiazide.氢氯噻嗪降低血压的代谢成本。

Diabetol Metab Syndr. 2013 Jul 9;5(1):35. doi: 10.1186/1758-5996-5-35.

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.临床应用的血管紧张素 II 型 1 受体拮抗剂的特性的系统比较。

Pharmacol Rev. 2013 Mar 13;65(2):809-48. doi: 10.1124/pr.112.007278. Print 2013 Apr.

Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.替米沙坦治疗对白细胞介素-6 和肿瘤坏死因子-α水平的影响：一项随机对照试验的荟萃分析。

Hypertens Res. 2013 Apr;36(4):368-73. doi: 10.1038/hr.2012.196. Epub 2012 Dec 13.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metabolic approaches to antihypertensive treatment in diabetic patients.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献